BioWorld Science

RSS

Elacestrant significantly reduced FES uptake in patients with ER+/HER2- breast cancer

Dec. 20, 2017

REGENXBIO's IND for study of RGX-121 in MPS II now active

Dec. 20, 2017

Pilot clinical study of Aclaris Therapeutics' ATI-50002 in vitiligo begins

Dec. 20, 2017

Shire reports topline results from phase II/III study of SHP-609

Dec. 20, 2017

Array BioPharma and Pfizer to jointly test several cancer drug combinations

Dec. 20, 2017

Twin epigenetic study reveals idiopathic epilepsy biomarkers

Dec. 20, 2017

BeiGene begins phase II study of pamiparib

Dec. 20, 2017

Bioharmony Therapeutics receives support to develop lysins for bacterial infections

Dec. 20, 2017

DelSiTech and C-TRI to jointly develop long-acting controlled release formulations

Dec. 20, 2017

Taiho Pharmaceutical discovers new ribonucleoside-diphosphate reductase inhibitors

Dec. 19, 2017